Trial Profile
Continuous subcutaneous infusions of different glucagon-like peptide 1 doses in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2011
Price :
$35
*
At a glance
- Drugs Glucagon-like peptide-1 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Jul 2011 New trial record
- 01 Jul 2011 Results published in Diabetes, Obesity and Metabolism.